Design and Molecular Simulation of a Rituximab-Methimazole Hybrid Compound for Selective Thyroid-Stimulating Hormone Receptor Inhibition in Graves’ Disease. (2025). Em SciELO Preprints. https://doi.org/10.1590/SciELOPreprints.12615